150 related articles for article (PubMed ID: 11091773)
21. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
Stone VE
Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
[TBL] [Abstract][Full Text] [Related]
22. Predictors of short-term success of antiretroviral therapy in HIV infection.
Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
[TBL] [Abstract][Full Text] [Related]
23. HIV-related knowledge and adherence to HAART.
Weiss L; French T; Finkelstein R; Waters M; Mukherjee R; Agins B
AIDS Care; 2003 Oct; 15(5):673-9. PubMed ID: 12959818
[TBL] [Abstract][Full Text] [Related]
24. Correlates of HIV antiretroviral adherence in persons with serious mental illness.
Wagner GJ; Kanouse DE; Koegel P; Sullivan G
AIDS Care; 2004 May; 16(4):501-6. PubMed ID: 15203417
[TBL] [Abstract][Full Text] [Related]
25. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
[TBL] [Abstract][Full Text] [Related]
26. Influencing medication adherence among women with AIDS.
Jones DL; Ishii M; LaPerriere A; Stanley H; Antoni M; Ironson G; Schneiderman N; Van Splunteren F; Cassells A; Alexander K; Gousse YP; Vaughn A; Brondolo E; Tobin JN; Weiss SM
AIDS Care; 2003 Aug; 15(4):463-74. PubMed ID: 14509861
[TBL] [Abstract][Full Text] [Related]
27. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial.
Haug NA; Sorensen JL; Lollo ND; Gruber VA; Delucchi KL; Hall SM
AIDS Care; 2005 Nov; 17(8):1022-9. PubMed ID: 16176898
[TBL] [Abstract][Full Text] [Related]
28. What is a missed dose? Implications for construct validity and patient adherence.
Sankar AP; Nevedal DC; Neufeld S; Luborsky MR
AIDS Care; 2007 Jul; 19(6):775-80. PubMed ID: 17573598
[TBL] [Abstract][Full Text] [Related]
29. The relationship of disease severity, health beliefs and medication adherence among HIV patients.
Gao X; Nau DP; Rosenbluth SA; Scott V; Woodward C
AIDS Care; 2000 Aug; 12(4):387-98. PubMed ID: 11091771
[TBL] [Abstract][Full Text] [Related]
30. Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes.
Walsh JC; Horne R; Dalton M; Burgess AP; Gazzard BG
AIDS Care; 2001 Dec; 13(6):709-20. PubMed ID: 11720641
[TBL] [Abstract][Full Text] [Related]
31. Adherence to antiretroviral therapy in children: a comparative evaluation of caregiver reports and physician judgement.
Albano F; Giacomet V; De Marco G; Bruzzese E; Starace F; Guarino A
AIDS Care; 2007 Jul; 19(6):764-6. PubMed ID: 17573596
[TBL] [Abstract][Full Text] [Related]
32. How well does self-reported adherence fare compared to therapeutic drug monitoring in HAART?
Bulgiba A; Mohammed UY; Chik Z; Lee C; Peramalah D
Prev Med; 2013; 57 Suppl():S34-6. PubMed ID: 23313585
[TBL] [Abstract][Full Text] [Related]
33. Barriers to use of electronic adherence monitoring in an HIV clinic.
Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
[TBL] [Abstract][Full Text] [Related]
34. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.
Wagner GJ
AIDS Patient Care STDS; 2002 Dec; 16(12):599-608. PubMed ID: 12542933
[TBL] [Abstract][Full Text] [Related]
35. Adherence to HIV medications in a cohort of men who have sex with men: impact of September 11th.
Halkitis PN; Kutnick AH; Rosof E; Slater S; Parsons JT
J Urban Health; 2003 Mar; 80(1):161-6. PubMed ID: 12612105
[TBL] [Abstract][Full Text] [Related]
36. Adherence--sticking to the evidence.
Sherr L
AIDS Care; 2000 Aug; 12(4):373-5. PubMed ID: 11091769
[No Abstract] [Full Text] [Related]
37. Electronic monitoring: adherence assessment or intervention?
Wagner GJ; Ghosh-Dastidar B
HIV Clin Trials; 2002; 3(1):45-51. PubMed ID: 11819185
[TBL] [Abstract][Full Text] [Related]
38. Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible.
Wiener L; Riekert K; Ryder C; Wood LV
AIDS Patient Care STDS; 2004 Sep; 18(9):527-38. PubMed ID: 15630773
[TBL] [Abstract][Full Text] [Related]
39. Placebo practice trials: a tool to assess and improve adherence readiness.
Wagner G; Iguchi M; Schneider S; Scott J; Anderson D
HIV Clin Trials; 2002; 3(6):475-81. PubMed ID: 12501131
[TBL] [Abstract][Full Text] [Related]
40. The role of HIV serostatus disclosure in antiretroviral medication adherence.
Stirratt MJ; Remien RH; Smith A; Copeland OQ; Dolezal C; Krieger D;
AIDS Behav; 2006 Sep; 10(5):483-93. PubMed ID: 16721505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
